Translation efficiencies of the 5′-untranslated region of genotypes 1a and 3a in hepatitis C infected patients

Journal of Medical Virology

Volumn 79, Issue 3, 2007, Pages 259-269

  Motazakker, M ^a,c   Preikschat, P ^a   Elliott, J ^a   Smith, C A ^a   Mills, P R ^b   Oien, K ^b   Spence, E ^b   Elliott, R M ^a,d   McCruden, E A B ^a,e  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^c Uromieh University of Medical Science   (Iran)

^d UNIVERSITY OF ST ANDREWS   (United Kingdom)

^e GBRC ^*  (United Kingdom)

Author keywords

Chronic hepatitis; HCV; IRES; Liver biopsy; Majority sequence; Steatosis

Indexed keywords

LUCIFERASE; VIRUS RNA;

5' UNTRANSLATED REGION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DISEASE SEVERITY; FATTY LIVER; GENE SEQUENCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER LEVEL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; RNA TRANSLATION; VIRUS LOAD;

5' UNTRANSLATED REGIONS; ANIMALS; ARTIFICIAL GENE FUSION; CELL LINE; CLONING, MOLECULAR; CRICETINAE; FATTY LIVER; GENES, REPORTER; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER; LIVER CIRRHOSIS; LUCIFERASES; PROTEIN BIOSYNTHESIS; SEQUENCE ANALYSIS, DNA; SERUM; STATISTICS; VIRAL LOAD;

HEPATITIS C VIRUS; VIBRIO PHAGE NT-1;

EID: 33846828513     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20794     Document Type: Article

References (28)

1. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. 2001. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33:1358-1364.
2. Agapov EV, Frolov I, Lindenbach BD, Pragai BM, Schlesinger S, Rice CM. 1998. Noncytopathic Sindbis virus RNA vectors for heterologous gene expression. Proc Natl Acad Sci USA 95:12989-12994.
3. Brown EA, Zhang H, Ping LH, Lemon SM. 1992. Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res 20:5041-5045.
4. Buratti E, Gerotto M, Pontisso P, Alberti A, Tisminetzky SG, Baralle FE. 1997. In vivo translational efficiency of different hepatitis C virus 5′-UTRs. FEBS Lett 411:275-280.
5. Collier AJ, Tang S, Elliott RM. 1998. Translation efficiencies of the 5′ untranslated region from representatives of the six major genotypes of hepatitis C virus using a novel bicistronic reporter assay system. J Gen Virol 79:2359-2366.
6. Fuerst TR, Niles EG, Studier FW, Moss B. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci USA 83:8122-8126.
7. Hezode C, Roudot-Thoraval F, Zafrani ES, Dhumeaux D, Pawlotsky JM. 2004. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections. J Viral Hepat 11:455-458.
8. Honda M, Brown EA, Lemon SM. 1996. Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA 2:955-968.
9. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RNM, Phillips MJ, Portmann BG, Poulsen H, Scheuer PJ, Schmid M, Thaler H. 1995. Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699.
10. Kamoshita N, Tsukiyama-Kohara K, Kohara M, Nomoto A. 1997. Genetic analysis of internal ribosomal entry site on hepatitis C virus RNA: Implication for involvement of the highly ordered structure and cell type-specific transacting factors. Virology 233:9-18.
11. Kim YK, Lee SH, Kim CS, Seol SK, Jang SK. 2003. Long-range RNA-RNA interaction between the 5′ nontranslated region and the core-coding sequences of hepatitis C virus modulates the IRES-dependent translation. RNA 9:599-606.
12. Laporte J, Malet I, Andrieu T, Thibault V, Toulme JJ, Wychowski C, Pawlotsky JM, Huraux JM, Agut H, Cahour A. 2000. Comparative analysis of translation efficiencies of hepatitis C virus 5′ untranslated regions among intraindividual quasispecies present in chronic infection: Opposite behaviors depending on cell type. J Virol 74:10827-10833.
13. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V, et al. 1995. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 22:1050-1056.
14. McHutchinson JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK. 1998. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339:1485-1492.
15. Rose JK, Buonocore L, Whitt MA. 1991. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechniques 10:520-525.
16. Rubbia-Brandt L, Fabris P, Paganin S, Leandro G, Male P-J, Giostra E, Carlotto A, Bozzola L, Smedile A, Negro F. 2004. Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut 53:406-412.
17. Saldanha J. 1999. Standardization: A progress report. Biologicals 27:285-289.
18. Shimoike T, Mimori S, Tani H, Matsuura Y, Miyamura T. 1999. Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation. J Virol 73:9718-9725.
19. Soler M, Pellerin M, Malnou CE, Dhumeaux D, Kean KM, Pawlotsky JM. 2002. Quasispecies heterogeneity and constraints on the evolution of the 5′ noncoding region of hepatitis C virus (HCV): Relationship with HCV resistance to interferon-alpha therapy. Virology 298:160-173.
20. Thelu MA, Drouet E, Hilleret MN, Zarski JP. 2004. Lack of clinical significance of variability in the internal ribosome entry site of hepatitis C virus. J Med Virol 72:396-405.
21. Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A. 1992. Internal ribosome entry site within hepatitis C virus RNA. J Virol 66:1476-1483.
22. Varaklioti A, Georgopoulou U, Kakkanas A, Psaridi L, Serwe M, Caselmann WH, Mavromara P. 1998. Mutational analysis of two unstructured domains of the 5′ untranslated region of HCV RNA. Biochem Biophys Res Commun 253:678-685.
23. Wang C, Sarnow P, Siddiqui A. 1993. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J Virol 67:3338-3344.
24. Wang T-H, Rijnbrand RCA, Lemon SM. 2000. Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus. J. Virol 74:11347-11358.
25. Yamamoto C, Enomoto N, Kurosaki M, Yu SH, Tazawa J, Izumi N, Marumo F, Sato C. 1997. Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: No association with efficacy of interferon therapy or serum HCV-RNA levels. Hepatology 26:1616-1620.
26. Yasmeen A, Hamid S, Granath FN, Lindstrom H, Elliott RM, Siddiqui AA, Persson MAA. 2006. Correlation between translation efficiency and outcome of combination therapy in chronic hepatitis C genotype 3. J Viral Hepat 13:87-95.
27. Zhang J, Yamada O, Yoshida H, Iwai T, Araki H. 2002. Autogenous translational inhibition of core protein: Implication for switch from translation to RNA replication in hepatitis C virus. Virology 293:141-150.
28. Zeuzem S, Franke A, Lee JH, Herrmann G, Ruster B, Roth WK. 1996. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests and histology. Hepatology 24:1003-1009.